The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
In general, longer is better, and long telomeres, genetically, or measured in the blood, predict less heart disease, less metabolic disease. But actually, longer telomeres, especially when you measure the genetic index but sometimes also when you measure in the blood, long telomeres also predict greater risk of certain cancers. like glioma, melanoma, and several others.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.